The Detection of Vaccine Virus and Protection of a Modified Live, Intranasal, Trivalent Vaccine in Neonatal, Colostrum-Fed Calves with an Experimental Bovine Respiratory Syncytial Virus Challenge

Overview

Journal Pathogens

Date 2024 Jun 26

PMID 38921814

Authors

Stephanie Perkins-Oines

Nirosh D Senevirathne

Greta M Krafsur

Karim Abdelsalam

David Renter

Brent Meyer

Christopher C L Chase

Affiliations

Soon will be listed here.

Abstract

The efficacy of an intranasal (IN) bovine respiratory syncytial virus (BRSV) vaccine administered in the presence of passive immunity was assessed. Pooled colostrum was administered by intubation to 50 beef-dairy crossbred calves the day they were born. The calves were transported to a research facility and were blocked by age and sex, and randomly assigned into two groups: sham-vaccinated intranasally with a placebo (sterile water) or vaccinated with a trivalent (BRSV, bovine herpesvirus 1 and bovine parainfluenza 3) modified live viral (MLV) vaccine. The calves were 9 ± 2 days old when vaccinated (day 0). The calves were challenged by aerosolized BRSV on days 80 and 81 as a respiratory challenge. The study was terminated on day 88. Lung lesion scores (LLS) were significantly lower for calves vaccinated with trivalent MLV vaccine than those for calves that were sham-vaccinated. Serum neutralization (SN) antibody against BRSV in calves vaccinated with the trivalent MLV vaccine demonstrated an anamnestic response on day 88. After challenge, the calves sham-vaccinated with the placebo lost weight, while those vaccinated with the trivalent MLV vaccine gained weight. In this study, colostrum-derived antibodies did not interfere with the immune response or protection provided by one dose of the trivalent MLV vaccine.

References

Flynn A, McAloon C, Sugrue K, Fitzgerald R, Sheridan C, Cowley B . Investigation into the safety, and serological responses elicited by delivery of live intranasal vaccines for bovine herpes virus type 1, bovine respiratory syncytial virus, and parainfluenza type 3 in pre-weaned calves. Front Vet Sci. 2024; 11:1283013. PMC: 10920262. DOI: 10.3389/fvets.2024.1283013. View

Cortese V, Woolums A, Hurley D, Berghaus R, Bernard J, Short T . Comparison of interferon and bovine herpesvirus-1-specific IgA levels in nasal secretions of dairy cattle administered an intranasal modified live viral vaccine prior to calving or on the day of calving. Vet Immunol Immunopathol. 2017; 187:35-41. DOI: 10.1016/j.vetimm.2017.04.003. View

Chamorro M, Walz P, Haines D, Passler T, Earleywine T, Palomares R . Comparison of levels and duration of detection of antibodies to bovine viral diarrhea virus 1, bovine viral diarrhea virus 2, bovine respiratory syncytial virus, bovine herpesvirus 1, and bovine parainfluenza virus 3 in calves fed maternal colostrum.... Can J Vet Res. 2014; 78(2):81-8. PMC: 3962282. View

Kimman T, Westenbrink F, Straver P . Priming for local and systemic antibody memory responses to bovine respiratory syncytial virus: effect of amount of virus, virus replication, route of administration and maternal antibodies. Vet Immunol Immunopathol. 1989; 22(2):145-60. DOI: 10.1016/0165-2427(89)90057-3. View

Vangeel I, Antonis A, Fluess M, Riegler L, Peters A, Harmeyer S . Efficacy of a modified live intranasal bovine respiratory syncytial virus vaccine in 3-week-old calves experimentally challenged with BRSV. Vet J. 2006; 174(3):627-35. DOI: 10.1016/j.tvjl.2006.10.013. View

White B, Larson B . Impact of bovine respiratory disease in U.S. beef cattle. Anim Health Res Rev. 2020; 21(2):132-134. DOI: 10.1017/S1466252320000079. View

Fulton R, Briggs R, Payton M, Confer A, Saliki J, Ridpath J . Maternally derived humoral immunity to bovine viral diarrhea virus (BVDV) 1a, BVDV1b, BVDV2, bovine herpesvirus-1, parainfluenza-3 virus bovine respiratory syncytial virus, Mannheimia haemolytica and Pasteurella multocida in beef calves, antibody.... Vaccine. 2004; 22(5-6):643-9. DOI: 10.1016/j.vaccine.2003.08.033. View

Jericho K, Langford E . Aerosol vaccination of calves with pasteurella haemolytica against experimental respiratory disease. Can J Comp Med. 1982; 46(3):287-92. PMC: 1320326. View

Short D, Lombard J . The National Animal Health Monitoring System's perspective on respiratory disease in dairy cattle. Anim Health Res Rev. 2021; 21(2):135-138. DOI: 10.1017/S1466252320000080. View

10.

Blakebrough-Hall C, McMeniman J, Gonzalez L . An evaluation of the economic effects of bovine respiratory disease on animal performance, carcass traits, and economic outcomes in feedlot cattle defined using four BRD diagnosis methods. J Anim Sci. 2020; 98(2). PMC: 6996507. DOI: 10.1093/jas/skaa005. View

11.

Achenbach J, Topliff C, Vassilev V, Donis R, Eskridge K, Kelling C . Detection and quantitation of bovine respiratory syncytial virus using real-time quantitative RT-PCR and quantitative competitive RT-PCR assays. J Virol Methods. 2004; 121(1):1-6. DOI: 10.1016/j.jviromet.2004.05.004. View

12.

Fairbanks K, Campbell J, Chase C . Rapid onset of protection against infectious bovine rhinotracheitis with a modified-live virus multivalent vaccine. Vet Ther. 2004; 5(1):17-25. View

13.

Timsit E, Maingourd C, Le Drean E, Belloc C, Seegers H, Douart A . Evaluation of a commercial real-time reverse transcription polymerase chain reaction kit for the diagnosis of Bovine respiratory syncytial virus infection. J Vet Diagn Invest. 2010; 22(2):238-41. DOI: 10.1177/104063871002200211. View

14.

Ellis J, Gow S, Goji N . Response to experimentally induced infection with bovine respiratory syncytial virus following intranasal vaccination of seropositive and seronegative calves. J Am Vet Med Assoc. 2010; 236(9):991-9. DOI: 10.2460/javma.236.9.991. View

15.

Chase C, Hurley D, Reber A . Neonatal immune development in the calf and its impact on vaccine response. Vet Clin North Am Food Anim Pract. 2008; 24(1):87-104. PMC: 7127081. DOI: 10.1016/j.cvfa.2007.11.001. View

16.

Makoschey B, Berge A . Review on bovine respiratory syncytial virus and bovine parainfluenza - usual suspects in bovine respiratory disease - a narrative review. BMC Vet Res. 2021; 17(1):261. PMC: 8325295. DOI: 10.1186/s12917-021-02935-5. View

17.

Ellis J . How efficacious are vaccines against bovine respiratory syncytial virus in cattle?. Vet Microbiol. 2016; 206:59-68. DOI: 10.1016/j.vetmic.2016.11.030. View

18.

Todd J, Volenec F, PATON I . Interferon in nasal secretions and sera of calves after intranasal administration of avirulent infectious bovine rhinotracheitis virus: association of interferon in nasal secretions with early resistance to challenge with virulent virus. Infect Immun. 1972; 5(5):699-706. PMC: 422428. DOI: 10.1128/iai.5.5.699-706.1972. View

19.

Windeyer M, Gamsjager L . Vaccinating Calves in the Face of Maternal Antibodies: Challenges and Opportunities. Vet Clin North Am Food Anim Pract. 2019; 35(3):557-573. DOI: 10.1016/j.cvfa.2019.07.004. View

20.

. Preview: Economic Effects of Bovine Respiratory Disease. J Anim Sci. 2020; 98(2). PMC: 7043139. DOI: 10.1093/jas/skaa042. View